Awards for “TEVA PHARMACEUTICALS USA, INC.”
25 awards on this page · sorted by amount · page 18
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| SPE2DP24F7998 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-09-18 | 2024-09-24 | 325412 | 8510902082!ADENOVIRUS TYPE 4 A |
| SPE2DP24F7997 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-09-18 | 2024-09-24 | 325412 | 8510902081!ADENOVIRUS TYPE 4 A |
| SPE2DP24F7995 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-09-18 | 2024-09-24 | 325412 | 8510902037!ADENOVIRUS TYPE 4 A |
| SPE2DP24F7170 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-08-22 | 2024-08-27 | 325412 | 8510839848!ADENOVIRUS TYPE 4 A |
| SPE2DP24F7168 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-08-22 | 2024-08-27 | 325412 | 8510839846!ADENOVIRUS TYPE 4 A |
| SPE2DP24F7166 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-08-22 | 2024-08-27 | 325412 | 8510839841!ADENOVIRUS TYPE 4 A |
| SPE2DP24F6271 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-07-19 | 2024-07-30 | 325412 | 8510767086!ADENOVIRUS TYPE 4 A |
| SPE2DP24F6266 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-07-19 | 2024-07-30 | 325412 | 8510767026!ADENOVIRUS TYPE 4 A |
| SPE2DP24F6265 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-07-19 | 2024-07-30 | 325412 | 8510767021!ADENOVIRUS TYPE 4 A |
| SPE2DP24F5488 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-06-13 | 2024-06-25 | 325412 | 8510688489!ADENOVIRUS TYPE 4 A |
| SPE2DP24F5484 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-06-13 | 2024-06-25 | 325412 | 8510688483!ADENOVIRUS TYPE 4 A |
| SPE2DP24F5482 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-06-13 | 2024-06-25 | 325412 | 8510688378!ADENOVIRUS TYPE 4 A |
| SPE2DP24F4775 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-05-15 | 2024-05-21 | 325412 | 8510634437!ADENOVIRUS TYPE 4 A |
| SPE2DP24F3912 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-04-09 | 2024-04-30 | 325412 | 8510559017!ADENOVIRUS TYPE 4 A |
| SPE2DP24F3910 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-04-09 | 2024-04-30 | 325412 | 8510559012!ADENOVIRUS TYPE 4 A |
| SPE2DP24F3909 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-04-09 | 2024-04-30 | 325412 | 8510558936!ADENOVIRUS TYPE 4 A |
| SPE2DP24F3175 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-03-13 | 2024-03-26 | 325412 | 8510500537!ADENOVIRUS TYPE 4 A |
| SPE2DP24F3170 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-03-13 | 2024-03-26 | 325412 | 8510500396!ADENOVIRUS TYPE 4 A |
| SPE2DP24F2835 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-02-22 | 2024-02-27 | 325412 | 8510462472!ADENOVIRUS TYPE 4 A |
| SPE2DP24F2834 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $158.8K | 2024-02-22 | 2024-02-27 | 325412 | 8510462405!ADENOVIRUS TYPE 4 A |
| SPE2DP24F1227 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $152.7K | 2023-12-14 | 2023-12-19 | 325412 | 8510325361!ADENOVIRUS TYPE 4 A |
| SPE2DP23F6115 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $152.7K | 2023-09-12 | 2023-09-19 | 325412 | 8510134901!ADENOVIRUS TYPE 4 A |
| SPE2DP23F6112 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $152.7K | 2023-09-12 | 2023-09-19 | 325412 | 8510134516!ADENOVIRUS TYPE 4 A |
| SPE2DP23F5006 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $152.7K | 2023-07-18 | 2023-07-25 | 325412 | 8510016820!ADENOVIRUS TYPE 4 A |
| SPE2DP23F3965 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $152.7K | 2023-05-17 | 2023-05-23 | 325412 | 8509896007!ADENOVIRUS TYPE 4 A |